Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management

Background: Circulating tumor DNA (ctDNA) in the blood plasma of cancer patients is an emerging biomarker used across oncology, facilitating noninvasive disease monitoring and genetic profiling at various disease milestones. Digital droplet PCR (ddPCR) technologies have demonstrated high sensitivity...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diagnostics (Basel)
Huvudupphovsmän: Wehrle, Julius, Philipp, Ulrike, Jolic, Martina, Follo, Marie, Hussung, Saskia, Waldeck, Silvia, Deuter, Max, Rassner, Michael, Braune, Jan, Rawluk, Justyna, Greil, Christine, Waller, Cornelius F., Becker, Heiko, Duque-Afonso, Jesús, Illert, Anna L., Fritsch, Ralph M., Meiss, Frank, Duyster, Justus, von Bubnoff, Nikolas, Scherer, Florian
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7459590/
https://ncbi.nlm.nih.gov/pubmed/32748806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10080550
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk